Coverage
-
September 05, 2014
A Maryland federal judge on Friday said the U.S. Food and Drug Administration's recent approval of generic versions of Hospira Inc.'s blockbuster sedative Precedex wasn't arbitrary or capricious, finding that the agency's decision was "entirely consistent" with its established practice of approving generic drugs.
3 other articles on this case.
View all »